NCT03959462 - Supporting Decisions With Transcranial Direct Current Stimulation in Healthy Young and Elderly Individuals | Biotech Hunter

Enrollment

254

Participants

Timeline

Start Date

March 6, 2018

Primary Completion Date

August 30, 2022

Study Completion Date

December 30, 2022

Conditions

Real tDCSSham tDCS

Interventions

DEVICE

real anodal transcranial direct current stimulation

A neuroConn DC-Stimulator PLUS (neuroCare Group, Ilmenau, Germany) will be used.

DEVICE

sham transcranial direct current stimulation

A neuroConn DC-Stimulator PLUS (neuroCare Group, Ilmenau, Germany) will be used.

Trial Locations (1)

Klinik für Alterspsychiatrie und Psychotherapie UPD Bern, Bern